Metabolic risks and effects of atypical antipsychotic treatment.

Daniel (Dan) Haupt, John M. Kane

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Weight gain and the associated increased risk of diabetes and cardiovascular disease may be problems for individuals who receive long-term treatment with atypical antipsychotics. Atypical antipsychotics differ in their propensity to cause obesity and other metabolic disturbances. If a patient gains substantial weight while taking atypical antipsychotics, the physician should consider switching him or her to a drug with a lower risk of weight gain. The physician should also address patient lifestyle issues such as a poor diet and lack of exercise.

Original languageEnglish (US)
JournalJournal of Clinical Psychiatry
Volume68
Issue number10
StatePublished - Oct 2007
Externally publishedYes

Fingerprint

Antipsychotic Agents
Weight Gain
Physicians
Life Style
Cardiovascular Diseases
Therapeutics
Obesity
Exercise
Diet
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Metabolic risks and effects of atypical antipsychotic treatment. / Haupt, Daniel (Dan); Kane, John M.

In: Journal of Clinical Psychiatry, Vol. 68, No. 10, 10.2007.

Research output: Contribution to journalArticle

@article{ca836db586e6464382edb81136f9f41d,
title = "Metabolic risks and effects of atypical antipsychotic treatment.",
abstract = "Weight gain and the associated increased risk of diabetes and cardiovascular disease may be problems for individuals who receive long-term treatment with atypical antipsychotics. Atypical antipsychotics differ in their propensity to cause obesity and other metabolic disturbances. If a patient gains substantial weight while taking atypical antipsychotics, the physician should consider switching him or her to a drug with a lower risk of weight gain. The physician should also address patient lifestyle issues such as a poor diet and lack of exercise.",
author = "Haupt, {Daniel (Dan)} and Kane, {John M.}",
year = "2007",
month = "10",
language = "English (US)",
volume = "68",
journal = "Journal of Clinical Psychiatry",
issn = "0160-6689",
publisher = "Physicians Postgraduate Press Inc.",
number = "10",

}

TY - JOUR

T1 - Metabolic risks and effects of atypical antipsychotic treatment.

AU - Haupt, Daniel (Dan)

AU - Kane, John M.

PY - 2007/10

Y1 - 2007/10

N2 - Weight gain and the associated increased risk of diabetes and cardiovascular disease may be problems for individuals who receive long-term treatment with atypical antipsychotics. Atypical antipsychotics differ in their propensity to cause obesity and other metabolic disturbances. If a patient gains substantial weight while taking atypical antipsychotics, the physician should consider switching him or her to a drug with a lower risk of weight gain. The physician should also address patient lifestyle issues such as a poor diet and lack of exercise.

AB - Weight gain and the associated increased risk of diabetes and cardiovascular disease may be problems for individuals who receive long-term treatment with atypical antipsychotics. Atypical antipsychotics differ in their propensity to cause obesity and other metabolic disturbances. If a patient gains substantial weight while taking atypical antipsychotics, the physician should consider switching him or her to a drug with a lower risk of weight gain. The physician should also address patient lifestyle issues such as a poor diet and lack of exercise.

UR - http://www.scopus.com/inward/record.url?scp=38449111884&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38449111884&partnerID=8YFLogxK

M3 - Article

VL - 68

JO - Journal of Clinical Psychiatry

JF - Journal of Clinical Psychiatry

SN - 0160-6689

IS - 10

ER -